These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26218766)

  • 21. Testim 1% testosterone gel for the treatment of male hypogonadism.
    Bouloux P
    Clin Ther; 2005 Mar; 27(3):286-98. PubMed ID: 15878382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testosterone supplementation: why and for whom?
    Gooren L
    Aging Male; 2003 Sep; 6(3):184-99. PubMed ID: 14628499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Safety of Testosterone Dosage Forms.
    Layton JB; Meier CR; Sharpless JL; Stürmer T; Jick SS; Brookhart MA
    JAMA Intern Med; 2015 Jul; 175(7):1187-96. PubMed ID: 25962056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testosterone replacement therapy: who to evaluate, what to use, how to follow, and who is at risk?
    Afiadata A; Ellsworth P
    Hosp Pract (1995); 2014 Dec; 42(5):69-82. PubMed ID: 25485919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-year follow-up of androgen treatment in hypogonadal men: preliminary report with testosterone gel.
    Swerdloff RS; Wang C
    Aging Male; 2003 Sep; 6(3):207-11. PubMed ID: 14628501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new 2% testosterone gel formulation: a comparison with currently available topical preparations.
    Arver S; Stief C; de la Rosette J; Jones TH; Neijber A; Carrara D
    Andrology; 2018 May; 6(3):396-407. PubMed ID: 29600542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case Study: Absorption of Testosterone Cream via Scrotal Delivery.
    Needham S; Needham S
    Int J Pharm Compd; 2018; 22(6):466-468. PubMed ID: 30384346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clomiphene citrate and testosterone gel replacement therapy for male hypogonadism: efficacy and treatment cost.
    Taylor F; Levine L
    J Sex Med; 2010 Jan; 7(1 Pt 1):269-76. PubMed ID: 19694928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adequacy of androgen replacement influences bone density response to testosterone in androgen-deficient men.
    Aminorroaya A; Kelleher S; Conway AJ; Ly LP; Handelsman DJ
    Eur J Endocrinol; 2005 Jun; 152(6):881-6. PubMed ID: 15941928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of testosterone gel treatment on spermatogenesis in men with hypogonadism.
    George M; Yulia T; Svetlana K
    Gynecol Endocrinol; 2014 Oct; 30 Suppl 1():22-4. PubMed ID: 25200823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compounded percutaneous testosterone gel: use and effects in hypogonadal men.
    Cutter CB
    J Am Board Fam Pract; 2001; 14(1):22-32. PubMed ID: 11206690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The long-term efficacy and safety of a testosterone mucoadhesive buccal tablet in testosterone-deficient men.
    Dinsmore WW; Wyllie MG
    BJU Int; 2012 Jul; 110(2):162-9. PubMed ID: 22288877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current topics in testosterone replacement of hypogonadal men.
    Nieschlag E
    Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):77-90. PubMed ID: 25617174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testosterone supplementation does not worsen lower urinary tract symptoms.
    Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT
    J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of androgen supplementation therapy on partial androgen deficiency in the aging male: a preliminary study.
    Li JY; Zhu JC; Dou JT; Bai WJ; Deng SM; Li M; Huang W; Jin H
    Aging Male; 2002 Mar; 5(1):47-51. PubMed ID: 12040975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 12-month observation of testosterone replacement effectiveness in a general population of men.
    Miner MM; Bhattacharya RK; Blick G; Kushner H; Khera M
    Postgrad Med; 2013 Mar; 125(2):8-18. PubMed ID: 23816767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One-year efficacy and safety study of a 1.62% testosterone gel in hypogonadal men: results of a 182-day open-label extension of a 6-month double-blind study.
    Kaufman JM; Miller MG; Fitzpatrick S; McWhirter C; Brennan JJ
    J Sex Med; 2012 Apr; 9(4):1149-61. PubMed ID: 22321357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Androgen deficiency in aging and metabolically challenged men.
    Shelton JB; Rajfer J
    Urol Clin North Am; 2012 Feb; 39(1):63-75. PubMed ID: 22118346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry.
    Blick G; Khera M; Bhattacharya RK; Kushner H; Miner MM
    Postgrad Med; 2013 Mar; 125(2):19-29. PubMed ID: 23816768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral testosterone undecanoate (Andriol) supplement therapy improves the quality of life for men with testosterone deficiency.
    Park NC; Yan BQ; Chung JM; Lee KM
    Aging Male; 2003 Jun; 6(2):86-93. PubMed ID: 12898792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.